Bakuchi for Skin Rejuvenation - Quick Reference Sheet
evipedia.ai
← Back

Bakuchi for Skin Rejuvenation

Created on 09/18/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Bakuchi is one plant sold as two different products. The purified constituent, bakuchiol, applied to the face, reduced wrinkles and lightened dark patches over twelve weeks and was well tolerated. The whole seed and its oil carry light-activated compounds that burn skin; oral use of the seed is linked to liver injury. Evidence is thin and mostly manufacturer-funded. (Full Review)

Protocol

Standard concentration and frequency
0.5% bakuchiol cream twice daily
Applied to the full face; commercial serums run 0.5% to 2%
Minimum duration
12 weeks
Trials measured at 4, 8 and 12 weeks; wrinkle and pigment changes clearest at 12 weeks
Time of day
Morning and evening
Bakuchiol is not degraded by light, so morning application is workable; the trial regimen used both
Time to effect
Fine wrinkles
12 weeks
Measured at 12 weeks in the randomized trial; largest change between weeks 8 and 12
Hyperpigmentation
12 weeks
Pigment change was measured at 12 weeks; a 4-week reading falls before the trials' measured endpoint
Barrier and hydration
4 weeks
Instrumental barrier and hydration changes appeared by 4 weeks

Benefits

Contraindications
  • Pregnancy and lactation
  • Active or chronic liver disease (Child-Pugh Class B or C), or ALT above three times the upper limit of normal, for any oral preparation
  • Photosensitivity disorders (porphyria cutanea tarda, xeroderma pigmentosum, photosensitive lupus), for psoralen-containing preparations
  • Personal history of melanoma or non-melanoma skin cancer, or cumulative photochemotherapy exposure above 200 sessions, for psoralen-containing preparations
  • Documented bakuchiol contact allergy on patch testing, for any preparation
  • Children under 12 years, for seed and seed-oil preparations
  • Hormone-sensitive cancers, for oral seed preparations
  • Ultraviolet phototherapy and tanning devices, alongside seed-oil preparations
  • Photosensitizing prescription drugs (doxycycline, amiodarone, hydrochlorothiazide, voriconazole), with psoralen-containing seed oil
Key Interactions
  • Topical retinoids (tretinoin, adapalene, tazarotene)
  • Hepatotoxic prescription drugs (methotrexate, isoniazid, ketoconazole), with oral seed preparations
  • Over-the-counter exfoliants (salicylic acid, glycolic acid, benzoyl peroxide)
  • Over-the-counter photosensitizing analgesics (ibuprofen, naproxen, ketoprofen gel), with seed-oil preparations
  • Photosensitizing supplements (St John's wort, high-dose Angelica and bergamot preparations)
  • Liver-loading supplements (green tea catechin extract, kava, high-dose niacin), with oral seed preparations
  • Other topical actives with additive effect (vitamin C, niacinamide, azelaic acid)

Risk & Side Effects

  • High: Phototoxic burns and blistering from psoralen-containing preparations
  • Medium: Liver injury with oral seed preparations
    •
  • Low: Long-term skin cancer risk from repeated psoralen plus ultraviolet exposure; allergic contact dermatitis to bakuchiol; application-site irritation, dryness and stinging
  • Speculative: Estrogen-like activity of seed constituents; systemic exposure from large-area or covered application

Monitoring

Marker Target Why
ALT 10–26 U/L Earliest marker of liver cell injury
AST 10–26 U/L Confirms a liver signal and separates it from muscle
ALP 60–90 U/L Detects the bile-flow pattern seen in rodent studies
GGT Below 20 U/L in men, below 15 U/L in women Confirms bile-duct involvement and flags oxidative stress
Total bilirubin 0.4–1.0 mg/dL Marks loss of liver clearance capacity
Standardized facial photography No established target; change from day-zero images Supplies the only outcome the trials actually measured

Cadence: Photography before the first application, then at 4, 8 and 12 weeks, then every 3 to 6 months. Liver enzymes before starting oral seed preparations, repeated at 8 to 12 weeks, then every 6 months while use continues, with immediate repeat testing if fatigue, nausea, dark urine or yellowing of the skin appears.

Qualitative Assessment

  • Skin smoothness on touch, which changed before visible wrinkle scores in open studies
  • Application-site stinging, burning or dryness, and whether it settles within the first two weeks
  • Evenness of tone in consistent lighting, distinct from overall lightness
  • Any unusual reaction to sun exposure, particularly where seed-derived material is involved
  • Makeup or moisturizer sitting differently on the skin, an early proxy for texture change
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.